Early Phase Research
First-in-human, dose escalation, PK/PD, and proof-of-concept studies in our state-of-the-art clinical pharmacology units.
FIHSAD/MADBioequivalence
Discuss your study
Solutions
Clinical solutions built for a modern drug-development era.
We blend operational excellence with digital innovation — adaptive designs, decentralized trials, and real-world evidence — to make studies faster, smarter, and more patient-friendly.
Late Phase Trials
Pivotal Phase III and confirmatory Phase IV programs delivered globally with risk-based monitoring and adaptive designs.
Phase IIIPhase IVAdaptive Design
Discuss your study
Real World Evidence
Observational studies, patient registries, and real-world data analytics to support regulatory and HEOR objectives.
RegistriesClaims dataHEOR
Discuss your study
Decentralized Trials (DCTs)
eConsent, telemedicine, wearables and home-based assessments expand access while preserving data quality.
eConsentWearablesHome Nursing
Discuss your study
Ready to advance your study
Partner with us to accelerate your drug development journey
From first-in-human trials to commercialization, our experts deliver the science, speed, and certainty pharma teams trust.